Dr H. F. Khorakiwala , a masters in Pharmaceutical Science with Advanced Management Programme of Harvard Business School founded Wockhardt, one of India's top generic drug makers in 1967. Its current market capitalisation is over $1 billion and presence in over ninety countries. He ventured into biotechnology in the pre-liberalisation era when biotechnology had little prospects of growth. He chose this name Wockhardt because it sounded like 'work hard,' which best defines his attitude and mission.

HIS Contribution to Healthcare Landscape in India ;

* His early setbacks drove him to instill a new culture and management style with-Customer-centric approach for faster growth, Participative management practices, Continuous innovations and Empowerment processes
* First recombinant human insulin in Asia
* Wockhardt Foundation-a mass social movement of one million warriors for nation building, upliftment of poor and needy.
* WHARF-Wockhardt HIV/AIDS Education and Research Foundation-to scale up training of paramedics and counsellors.

Change-Making Positions Held ;

* Ex-President of FICCI and IPA-Indian Pharmaceutical Alliance.
* Member of Board of Trade and National Manufacturing Competitiveness Council.
* Nominated by the Government of India to Advisory Board of CSIR and Indian Red
Cross Society.

Laurels Brought to Dr H. F. Khorakiwala ;

* Honorary Consul General of Sweden.
* 'Lifetime Achievement Awards by International Medical Integration Council 2003, and by India Healthcare Excellence.
* Pharma Excellence Award of India Express Group.
* Ernst & Young "Entrepreneur of the Award" in 2004.
* Giants Award for Outstanding Contribution to Business and Industry in 2003.
* Honorary Doctorate by Purdue University in 2010.

Impact Brought in the Lives of Common Indians ;

With a capacity to cater to 10 to 15 percent of world's major pharmaceuticals, Wockhardt Biotech Park in Aurangabad carries a potential of impacting a huge number of lives with its diverse manufacturing in bulk drugs, vaccines, medical nutrition, health products and hospitals.